FSSAI Cracks Down on Violations in Nutraceutical Labels
Why FSSAI Enforces Nutraceutical Labelling Norms
The Food Safety and Standards Authority of India has issued a critical regulatory directive to protect consumers. Consequently, food business operators must strictly follow mandatory nutraceutical labelling norms for all dietary formulations. Recent market audits revealed widespread non-compliance regarding botanical ingredients and cautionary declarations. Therefore, the apex regulator warned manufacturers of stern disciplinary action and potential license cancellation. Additionally, healthcare providers must understand these regulatory shifts to safeguard patient safety during clinical consultations.
The Food Safety and Standards Regulations of 2016 explicitly govern non-conventional dietary products. These categories include health supplements, nutraceuticals, and foods for special medical purposes. Furthermore, the framework establishes permissible concentration limits for plant-based extracts and botanical compounds. Manufacturers frequently bypass these parameters or fail to disclose exact herbal extracts. As a result, consumers face unpredictable risks from unmonitored physiological active compounds.
Mandatory Disclaimers and Botanical Ingredient Disclosures
Under current guidelines, companies must clearly specify every botanical part utilized in a formulation. For example, formulations containing extracts of leaves, roots, or seeds produce distinct physiological outcomes. Furthermore, regulators mandate clear cautionary statements for vulnerable populations, including pregnant women and young children. Manufacturers must also prominently state that a product is not intended for medicinal use. Moreover, brands cannot suggest or claim disease cure on commercial packaging.
Clinical Implications for Healthcare Professionals
Physicians regularly encounter patients who self-prescribe over-the-counter dietary supplements. However, improper labelling masks potential drug interactions and contraindicated botanical ingredients. For instance, specific herbal compounds can alter hepatic drug metabolism or worsen underlying chronic illnesses. Therefore, medical practitioners should actively screen supplement ingredients during routine clinical evaluations. Transparent labelling enables clinicians to identify adverse side effects rapidly and counsel vulnerable demographics effectively.
Frequently Asked Questions
Q1: What prompted the recent FSSAI advisory on nutraceutical labelling norms?
FSSAI issued the advisory after observing widespread non-compliance among manufacturers regarding cautionary warnings and botanical ingredient disclosures.
Q2: Can nutraceutical products legally claim to cure medical diseases in India?
No, FSSAI regulations strictly prohibit manufacturers from claiming disease prevention, treatment, or cure on nutraceutical labels.
Q3: Why must supplement labels declare the specific plant parts used?
Different plant parts possess varying physiological activities and toxicity profiles, making specific botanical declarations essential for consumer safety.
References
- FSSAI warns against violation of mandatory labelling norms for nutraceuticals,health supplements - ETHealthworld
- FSSAI directs food business operators to comply with labelling norms, warnings for plant-based ingredients - The New Indian Express
- Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016 - Food Safety and Standards Authority of India
